Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke

Perioperative antiemetic efficacy of dexamethasone versus 5-HT3 receptor antagonists: a meta-analysis and trial sequential analysis of randomized controlled trials

(2018) Preet Mohinder Singh et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke

(2018) Bruce C.V. Campbell et al.   NEW ENGLAND JOURNAL OF MEDICINE

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

(2018) William J. Powers et al.   STROKE

Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials

(2018) Na Xu et al.   Drug Design Development and Therapy

Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials

(2018) Babikir Kheiri et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Minimal Clinically Important Difference for Safe and Simple Novel Acute Ischemic Stroke Therapies

(2017) Jessica S. Cranston et al.   STROKE

Safety and efficacy of tenecteplase versus alteplase in acute coronary syndrome: a systematic review and meta-analysis of randomized trials

(2016) Alexandre Guillermin et al.   Archives of Medical Science

Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke PopulationClinical Perspective

(2016) Joon-Tae Kim et al.   CIRCULATION

Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials

(2016) Xuya Huang et al.   International Journal of Stroke

Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke

(2016) Craig S. Anderson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

(2014) Jonathan Emberson et al.   LANCET

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE